Publications

  1. Snozek CLH, Yee CI, Bryksin J, Dahal R, Gerson B, Gherasim C, Hauff KD, Heger N, Huestis MA, Johnson-Davis KL, Knezevic CE, Love SA, Melanson SEF, Noguez JH, Pikulski M, Roper S, Tyagi M, Warrington JS, Yang HS, Yang YK. Assessing knowledge gaps and educational needs in urine drug test interpretation among health care professionals. Am J Clin Pathol. 2024 Jul 26 Epub 2024 July 26
    View PubMed
  2. Karsten C, Grannas K, Bergman O, Moverare R, Roforth M, Willrich MAV, Snyder MR, Yang YK. Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation. AAPS J. 2024 Jul 24; 26 (5):86 Epub 2024 July 24
    View PubMed
  3. Merrigan SD, Yang YK, McMillin GA, Boyd JM. Detection of 41 Drugs and Metabolites in Urine with Internal Hydrolysis Control by Liquid Chromatography-Tandem Mass Spectrometry. Methods Mol Biol. 2024; 2737:229-247
    View PubMed
  4. Dunbar C, Kushnir MM, Yang YK. Correction to Glycosylation Profiling of Neoplastic Biomarker Alpha Fetoprotein through Intact Mass Protein Analysis. J Proteome Res. 2023 Jun 2; 22 (6):2150 Epub 2023 May 05
    View PubMed
  5. Dunbar C, Kushnir MM, Yang YK. Glycosylation Profiling of the Neoplastic Biomarker Alpha Fetoprotein through Intact Mass Protein Analysis. J Proteome Res. 2023 Jan 6; 22 (1):226-234 Epub 2022 Dec 21
    View PubMed
  6. Smith EA, Parker R, Genesi B, Yang YK. Have you caught that outlier yet? Evaluate the utility of repeat testing in nutritional and toxic element assessment. Clin Chim Acta. 2022 Mar 1; 528:84-89 Epub 2022 Jan 29
    View PubMed
  7. Yang YK, Genesi B, Adams AH. Collection Tubes Can Cause False Elevations in Occupational and Clinical Evaluation of Antimony Exposure. J Anal Toxicol. 2022 Feb 10 [Epub ahead of print]
    View PubMed
  8. McMillin GA, Johnson-Davis KL, Kelly BN, Scott B, Yang YK. Impact of the Opioid Epidemic on Drug Testing. Ther Drug Monit. 2021 Feb 1; 43 (1):14-24
    View PubMed
  9. Yang YK, Reichman HA, Bankhead CD, McNamee JA. Evaluate the comparability of two automated liquid handling systems for clinical toxicology assays. Drug Test Anal. 2021 Feb; 13 (2):404-411 Epub 2020 Sept 10
    View PubMed
  10. Yang YK, Johnson-Davis KL, Kelly BN, McMillin GA. Demand for Interpretation of a Urine Drug Testing Panel Reflects the Changing Landscape of Clinical Needs; Opportunities for the Laboratory to Provide Added Clinical Value. J Appl Lab Med. 2020 Sep 1; 5 (5):858-868
    View PubMed
  11. Yang Y, Wysocki E, Antwi K, Niederkofler E, Leung EKY, Lazar-Molnar E, Yeo KJ. Development and validation of a targeted affinity-enrichment and LC-MS/MS proteomics approach for the therapeutic monitoring of adalimumab. Clin Chim Acta. 2018 Aug; 483:308-314 Epub 2018 May 09
    View PubMed
  12. Yang Y, Yassan L, Leung EKY, Yeo KJ. Smith-Lemli-Opitz Syndrome in a newborn infant with developmental abnormalities and low endogenous cholesterol. Clin Chim Acta. 2018 Apr; 479:208-211 Epub 2018 Jan 31
    View PubMed
  13. Yang Y, Ehrlich BE. Structural studies of the C-terminal tail of polycystin-2 (PC2) reveal insights into the mechanisms used for the functional regulation of PC2. J Physiol. 2016 Aug 1; 594 (15):4141-9 Epub 2016 Apr 27
    View PubMed
  14. Yang Y, Rogers K, Wardle R, El-Khoury JM. High-throughput measurement of 25-hydroxyvitamin D by LC-MS/MS with separation of the C3-epimer interference for pediatric populations. Clin Chim Acta. 2016 Feb 15; 454:102-6 Epub 2016 Jan 06
    View PubMed
  15. Yang Y, Hodsdon ME, Lolis EJ, Ehrlich BE. Conformational dynamics of Ca2+-dependent responses in the polycystin-2 C-terminal tail. Biochem J. 2016 Feb 1; 473 (3):285-96 Epub 2015 Nov 16
    View PubMed
  16. Yang Y, Keeler C, Kuo IY, Lolis EJ, Ehrlich BE, Hodsdon ME. Oligomerization of the polycystin-2 C-terminal tail and effects on its Ca2+-binding properties. J Biol Chem. 2015 Apr 17; 290 (16):10544-54 Epub 2015 Feb 25
    View PubMed